Detalhe da pesquisa
1.
The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer.
Int J Cancer
; 145(7): 1970-1981, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30807643
2.
Radium-223 international early access program: results from the Spanish subset.
Future Oncol
; 14(1): 41-50, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29232987
3.
Sex differences in the diagnosis, treatment and prognosis of cancer: the rationale for an individualised approach.
Clin Transl Oncol
; 25(7): 2069-2076, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36802013
4.
Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI Era.
Eur Urol Oncol
; 4(3): 502-505, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31477526
5.
Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma.
PLoS One
; 9(1): e86263, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24475095